These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 24692395)
1. Implementation of the bethesda system for reporting thyroid cytopathology: interobserver concordance and reclassification of previously inconclusive aspirates. Pathak P; Srivastava R; Singh N; Arora VK; Bhatia A Diagn Cytopathol; 2014 Nov; 42(11):944-9. PubMed ID: 24692395 [TBL] [Abstract][Full Text] [Related]
2. A tertiary center's experience with second review of 3885 thyroid cytopathology specimens. Olson MT; Boonyaarunnate T; Aragon Han P; Umbricht CB; Ali SZ; Zeiger MA J Clin Endocrinol Metab; 2013 Apr; 98(4):1450-7. PubMed ID: 23436916 [TBL] [Abstract][Full Text] [Related]
3. The impact of atypia/follicular lesion of undetermined significance and repeat fine-needle aspiration: 5 years before and after implementation of the Bethesda System. Sullivan PS; Hirschowitz SL; Fung PC; Apple SK Cancer Cytopathol; 2014 Dec; 122(12):866-72. PubMed ID: 25078420 [TBL] [Abstract][Full Text] [Related]
4. Reclassifying formerly indeterminate thyroid FNAs using the Bethesda system reduces the number of inconclusive cases. Song JY; Chu YC; Kim L; Park IS; Han JY; Kim JM Acta Cytol; 2012; 56(2):122-9. PubMed ID: 22378073 [TBL] [Abstract][Full Text] [Related]
5. Application of the Bethesda System for Reporting Thyroid Cytopathology in the Eastern Province of Saudi Arabia: phase I pilot retrospective analysis. Al-Abbadi MA; Shareef SQ; Ali JA; Yousef MM Acta Cytol; 2013; 57(5):481-8. PubMed ID: 24021940 [TBL] [Abstract][Full Text] [Related]
6. Thyroid fine-needle aspiration reporting rates and outcomes before and after Bethesda implementation within a combined academic and community hospital system. Harvey AM; Mody DR; Amrikachi M Arch Pathol Lab Med; 2013 Nov; 137(11):1664-8. PubMed ID: 24168507 [TBL] [Abstract][Full Text] [Related]
7. Yield of repeat fine-needle aspiration biopsy and rate of malignancy in patients with atypia or follicular lesion of undetermined significance: the impact of the Bethesda System for Reporting Thyroid Cytopathology. Chen JC; Pace SC; Chen BA; Khiyami A; McHenry CR Surgery; 2012 Dec; 152(6):1037-44. PubMed ID: 23040711 [TBL] [Abstract][Full Text] [Related]
8. Analysis of the bethesda system for reporting thyroid cytopathology and similar precursor thyroid cytopathology reporting schemes. Wong LQ; Baloch ZW Adv Anat Pathol; 2012 Sep; 19(5):313-9. PubMed ID: 22885380 [TBL] [Abstract][Full Text] [Related]
9. Application of the Bethesda Classification for Thyroid Fine-Needle Aspiration: Institutional Experience and Meta-analysis. Krauss EA; Mahon M; Fede JM; Zhang L Arch Pathol Lab Med; 2016 Oct; 140(10):1121-31. PubMed ID: 27684984 [TBL] [Abstract][Full Text] [Related]
10. Thyroid fine-needle aspiration cytology: is there a place to virtual cytology? Gerhard R; Teixeira S; Gaspar da Rocha A; Schmitt F Diagn Cytopathol; 2013 Sep; 41(9):793-8. PubMed ID: 23441010 [TBL] [Abstract][Full Text] [Related]
11. The impact of implementation of the Bethesda System for Reporting Thyroid Cytopathology on the surgical treatment of thyroid nodules. Richmond BK; O'Brien BA; Mangano W; Thompson S; Kemper S Am Surg; 2012 Jun; 78(6):706-10. PubMed ID: 22643269 [TBL] [Abstract][Full Text] [Related]
12. Consistency in the Distribution of Bethesda System for Reporting Thyroid Cytology Categories Over 9 Years: A Single Institute, Retrospective Study. Harris M; Zloczower E; Pinhas S; Allon R; Zornitzki T; Malka L; Cohen Y; Lahav Y; Cohen O Endocr Pract; 2024 Jun; 30(6):546-550. PubMed ID: 38570016 [TBL] [Abstract][Full Text] [Related]
13. Fine needle aspiration cytology of nodular thyroid lesions: a 2-year experience of the Bethesda system for reporting thyroid cytopathology in a large regional and a university hospital, with histological correlation. Mastorakis E; Meristoudis C; Margari N; Pouliakis A; Leventakos K; Chroniaris N; Panayiotides I; Karakitsos P Cytopathology; 2014 Apr; 25(2):120-8. PubMed ID: 23551656 [TBL] [Abstract][Full Text] [Related]
14. Outcomes of the Bethesda system for reporting thyroid cytopathology: Real-life experience. Avior G; Dagan O; Shochat I; Frenkel Y; Tessler I; Meir A; Jaffe A; Cohen O Clin Endocrinol (Oxf); 2021 Mar; 94(3):521-527. PubMed ID: 32981060 [TBL] [Abstract][Full Text] [Related]
15. Diagnostic accuracy of Bethesda system for reporting thyroid cytopathology: an institutional perspective. Naz S; Hashmi AA; Khurshid A; Faridi N; Edhi MM; Kamal A; Khan M Int Arch Med; 2014; 7():46. PubMed ID: 25945126 [TBL] [Abstract][Full Text] [Related]
16. Application of the Bethesda System for Reporting Thyroid Cytopathology in the Eastern Province of Saudi Arabia: A Follow-Up Study. Alabdulqader NA; Shareef SQ; Ali JA; Yousef MM; Al-Abbadi MA Acta Cytol; 2015; 59(3):233-8. PubMed ID: 26044567 [TBL] [Abstract][Full Text] [Related]
17. Validation of the Bethesda System for Reporting Thyroid Cytopathology in a Danish tertiary centre. Madsen SH; Jespersen ML; Bonnema SJ; Rolighed L; Swan KZ Dan Med J; 2024 May; 71(6):. PubMed ID: 38847411 [TBL] [Abstract][Full Text] [Related]
18. The interobserver reproducibility of thyroid cytopathology using Bethesda Reporting System: analysis of 200 cases. Ahmed S; Ahmad M; Khan MA; Kazi F; Noreen F; Nawaz S; Sohail I J Pak Med Assoc; 2013 Oct; 63(10):1252-5. PubMed ID: 24392554 [TBL] [Abstract][Full Text] [Related]
19. Variability in the atypia of undetermined significance/follicular lesion of undetermined significance diagnosis in the Bethesda System for Reporting Thyroid Cytopathology: sources and recommendations. Ohori NP; Schoedel KE Acta Cytol; 2011; 55(6):492-8. PubMed ID: 22156456 [TBL] [Abstract][Full Text] [Related]
20. The Bethesda System for Reporting Thyroid Cytopathology is applicable to frozen section diagnosis in children. Arnold MA; Nicol KK Pediatr Dev Pathol; 2015; 18(2):139-45. PubMed ID: 25625563 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]